Who must an employer institute a medical surveillance program for?

A medical surveillance program is crucial for monitoring the health and safety of employees who are at risk due to exposure to hazardous materials. In the context of asbestos, this program is specifically targeted at employees who work with asbestos at or above the permissible exposure limit (PEL). This is because asbestos exposure can lead to serious health issues, including lung diseases and cancers, which can develop over time.

By instituting a medical surveillance program for these employees, employers can ensure early detection of potential asbestos-related illnesses. This includes regular health evaluations and monitoring of lung function, which are essential for identifying any adverse health effects resulting from exposure. The program provides necessary medical interventions based on findings and helps in determining whether employee exposure levels are adequately controlled.

Other options, although they address different aspects of workplace safety, do not specifically align with the targeted need for health monitoring based on asbestos exposure. A program solely for all employees exposed to any hazardous materials would dilute the effectiveness, as not all materials pose the same risk as asbestos. Similarly, monitoring employees who wear any type of respirator or those in administrative positions does not specifically address the unique health risks associated with asbestos exposure at levels that exceed the PEL.